Commonwealth American Financial Group Executes Letter of Intent to Acquire a 56 Acre Parcel of Land.
The parcel is situated in a very high growth area of North Central Florida. Prices in the area have dramatically increased in the last 18 months due to historically low interest rates and general growth and interest in the Florida Real Estate Market. The project will get under way upon a completed closing. The company will then also begin a sales and marketing campaign for the property.
Ms. Ryals, President and CEO, said: "We are very excited about this acquisition as it creates another revenue stream for the company. This type of acquisition is consistent with our goals and objectives in building the company's real estate/development division. We will continue to acquire additional real estate projects such as this that will yield high returns."
The mission of Commonwealth American Financial Group, Inc. is to invest in land development projects either as developer, joint venture partner, or lender and create mezzanine-financing opportunities. The company will also grow by acquiring subsidiaries in related fields such as construction, real estate brokerage-appraisal-management, in Florida, Texas and Louisiana.
The Company has established a website http://www.cwmf.net and trades under the symbol (Pink Sheets:CWFG).
FORWARD LOOKING STATEMENTS: This information includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel as related to the industry. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this issue.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 30, 2005|
|Previous Article:||Predix Pharmaceuticals Obtains Special Protocol Assessment for PRX-00023 Pivotal Study in Anxiety; Predix Also Initiates Phase Ib Clinical Trial for...|
|Next Article:||Bluegreen Corporation Names Lani M. Liber Senior Vice President of Owner Relations.|